<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Original Article: Comparing Different Forms of Structured Follow-Up Support in the Treatment of Multiple Health Risks for Chronic Disease: A Randomized Controlled Trial Protocol

Multiple DFM contributors collaborated on this Implementation Science publication.

minute read

by Brittany Manansala | August 5, 2026
Woman looking at her phone.

“Comparing Different Forms of Structured Follow-Up Support in the Treatment of Multiple Health Risks for Chronic Disease: A Randomized Controlled Trial Protocol.”

July 2026

Implementation Science

A study titled “Comparing Different Forms of Structured Follow-Up Support in the Treatment of Multiple Health Risks for Chronic Disease: A Randomized Controlled Trial Protocol” published in Implementation Science, features several contributors from the Department of Family Medicine (DFM).

From the article:

“Primary care clinics need effective, low-cost tools to screen for and address multiple health risks — and technology can provide important efficiencies. My Own Health Report (MOHR) is a web-based intervention with 3 core functions: (1) risk flagging; (2) goal-setting for patient-prioritized risks; and (3) providing resources. A prior randomized trial in primary care settings showed that MOHR was feasible and effective. However, we identified two key gaps: a need for a flexible menu of delivery options to adopt and sustain MOHR and a pragmatic way to provide structured follow-up.

We developed and pilot-tested two distinct primary implementation strategies to provide structured follow-up… We expect the implementation strategies compared will produce different levels of representative engagement, behavior change, cost, and practice value. These findings will inform pragmatic ways to improve outcomes important to patients, primary care, and society.”

DFM contributors include (individuals listed alphabetically): Elena Broaddus, PhD; Russell Glasgow, PhD; Andrea Nederveld, MD; Katy Trinkley, PharmD, PhD; and Jun Ying, PhD

Read more of this article. 

Comments